Growth Metrics

Bionano Genomics (BNGO) Receivables - Net (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Receivables - Net for 9 consecutive years, with $5.2 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 9.43% to $5.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 million through Dec 2025, up 9.43% year-over-year, with the annual reading at $5.2 million for FY2025, 9.43% up from the prior year.
  • Receivables - Net hit $5.2 million in Q4 2025 for Bionano Genomics, up from $4.5 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $9.8 million in Q4 2023 to a low of $2.0 million in Q1 2021.
  • Historically, Receivables - Net has averaged $5.8 million across 5 years, with a median of $5.5 million in 2022.
  • Biggest five-year swings in Receivables - Net: plummeted 64.61% in 2021 and later surged 176.81% in 2022.
  • Year by year, Receivables - Net stood at $5.6 million in 2021, then rose by 24.86% to $7.0 million in 2022, then soared by 39.59% to $9.8 million in 2023, then crashed by 51.52% to $4.8 million in 2024, then increased by 9.43% to $5.2 million in 2025.
  • Business Quant data shows Receivables - Net for BNGO at $5.2 million in Q4 2025, $4.5 million in Q3 2025, and $3.5 million in Q2 2025.